Reference entry
Crystagen (EDP)
EDP Tripeptide · Thymus Immune Bioregulator
Overview
Crystagen is a Khavinson bioregulator tripeptide (EDP) identified in thymalin with selective action on thymus tissues. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology, it immune function by stimulating normal lymphocyte proliferation while inhibiting tumor cell growth. Research shows…
Crystagen works through epigenetic regulation by influencing gene expression and protein synthesis in immune cells. It regulates the synthesis of heat-shock proteins, cytokines, and affects cell differentiation, proliferation, and apoptosis. The EDP peptide spontaneous proliferative activity of normal lymphocytes…
Normalizes immunogram in elderly patients with impaired immunity.
Restores immune function after infectious diseases.
Helps normalize immunity after radiation and chemotherapy exposure.
Mechanism
Crystagen is a Khavinson bioregulator tripeptide (EDP) identified in thymalin with selective action on thymus tissues. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology, it immune function by stimulating normal lymphocyte proliferation while inhibiting tumor cell growth. Research shows…
Crystagen works through epigenetic regulation by influencing gene expression and protein synthesis in immune cells. It regulates the synthesis of heat-shock proteins, cytokines, and affects cell differentiation, proliferation, and apoptosis. The EDP peptide spontaneous proliferative activity of normal lymphocytes…
Normalizes immunogram in elderly patients with impaired immunity.
Research areas
- Crystagen is a Khavinson bioregulator tripeptide (EDP) identified in thymalin with selective action on thymus tissues. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology, it immune function by stimulating normal lymphocyte proliferation while inhibiting tumor cell growth. Research shows…
- Crystagen works through epigenetic regulation by influencing gene expression and protein synthesis in immune cells. It regulates the synthesis of heat-shock proteins, cytokines, and affects cell differentiation, proliferation, and apoptosis. The EDP peptide spontaneous proliferative activity of normal lymphocytes…
- Normalizes immunogram in elderly patients with impaired immunity.
- Restores immune function after infectious diseases.
- Helps normalize immunity after radiation and chemotherapy exposure.
Research notes
- Generally well-tolerated
- Minimal side effects reported
- Active autoimmune flares (consult physician)
- Pregnancy or breastfeeding
Pharmacokinetics
- Helps normalize immunity after radiation and chemotherapy exposure.
Questions
Does Crystagen actually help athletes reduce respiratory infections?
Yes, research shows Crystagen doubled HSP gene expression in athletes and reduced respiratory infections in a study population. By enhancing heat-shock protein production and normalizing IL-6 expression, it strengthens immune resilience during heavy training stress when illness risk is elevated.
What percentage of elderly patients experience immune improvements with Crystagen?
Clinical research found Crystagen normalized immune function (immunogram) in 82% of elderly patients versus only 56% in the control group. This significant difference suggests it effectively reverses age-related immune decline, though results vary individually.
Is Crystagen safe to use if I have an active autoimmune condition?
Crystagen is an immune-stimulating peptide that may exacerbate active autoimmune flares since it lymphocyte proliferation and immune activation. Medical consultation is essential before using, especially during autoimmune disease flares. It's better suited for those with immunodeficiency than autoimmunity.
Can Crystagen help protect immune function after chemotherapy?
Yes, research shows Crystagen effectiveness for normalizing immunity after chemotherapy and radiation exposure. As a thymus-derived immune bioregulator, it supports recovery of lymphocyte populations and immune surveillance that are suppressed by cancer treatments.